United States  

Troubled Chandler pharma company sells off drug assets as part of bankruptcy

bizjournals Friday, 23 August 2019
Insys Therapeutics Inc, has entered into sales agreements to unload some of its drug assets for a combined $29.2 million as the Chandler-based pharmaceutical firm works through bankruptcy filing proceedings. Insys will sell its naloxone and epinephrine nasal sprays and related assets and equipment to Hikma Pharmaceuticals USA Inc. for $17 million, according to a filing with the Securities and Exchange Commission. Per the purchase agreement, Eatontown, New Jersey- based Hikma agreed to be responsible…
0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this